• OPEN AN ACCOUNT
Indian Indices
Sensex
73,895.74 315.20
( 0.43%)
Global Indices
Nasdaq
51,839.66 468.68
(0.91%)
Dow Jones
7,763.25 38.12
(0.49%)
Hang Seng
66,308.10 794.11
(1.21%)
Nikkei 225
10,694.57 14.58
(0.14%)
Forex
USD-INR
95.89 0.16
(0.16%)
EUR-INR
109.08 -0.12
(-0.11%)
GBP-INR
126.82 -0.30
(-0.24%)
JPY-INR
0.60 0.00
(-0.20%)

EQUITY - MARKET SCREENER

Venus Remedies Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
526953
INE411B01019
515.9180123
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VENUSREM
19.73
2232.42
EPS(TTM)
Face Value()
Div & Yield %
84.64
10
0.6
 

Fairchem Organics hits the roof after Q1 PAT zooms 8-fold YoY
Jul 27,2026
The company's standalone profit after tax surged 755.56% YoY and 171.27% QoQ to Rs 10.01 crore in Q1 FY27.

Revenue from operations increased 34.40% YoY and 50.64% QoQ to Rs 176.15 crore in the quarter ended 30 June 2026.

Profit before tax stood at Rs 13.64 crore in Q1 FY27, up 741.98% YoY and 188.37% QoQ.

Total expenses increased 25.68% YoY to Rs 162.86 crore. Cost of materials consumed rose 32.60% YoY to Rs 120.27 crore, while employee benefits expense increased 12.50% YoY to Rs 6.75 crore. Finance costs climbed 84% YoY to Rs 1.84 crore, while power and fuel expenses rose 5.12% YoY to Rs 6.98 crore. Depreciation and amortisation expenses increased 0.37% YoY to Rs 2.74 crore.

Fairchem Organics manufactures speciality chemicals and nutraceutical ingredients, with a strong presence in oleochemicals, catering to the food, personal care, pharmaceutical and industrial sectors.